Overview

The Study About the Efficacy of Oral Limaprost After Surgery for Cervical Myelopathy

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The limaprost alfadex can improve the surgical outcomes in patients with cervical myelopathy.
Phase:
Phase 3
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Alprostadil